Log in to save to my catalogue

Long washout periods between biologics for inflammatory bowel disease clinical trials are unnecessar...

Long washout periods between biologics for inflammatory bowel disease clinical trials are unnecessar...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2835278341

Long washout periods between biologics for inflammatory bowel disease clinical trials are unnecessary: A Canadian retrospective cohort study

About this item

Full title

Long washout periods between biologics for inflammatory bowel disease clinical trials are unnecessary: A Canadian retrospective cohort study

Publisher

United States: Wolters Kluwer

Journal title

The American journal of gastroenterology, 2023-12, Vol.118 (12), p.2290-2293

Language

English

Formats

Publication information

Publisher

United States: Wolters Kluwer

More information

Scope and Contents

Contents

To assess the safety of early vs late biologic switch in patients with inflammatory bowel disease.
In this retrospective study, we included patients with inflammatory bowel disease who underwent biologic switch between January 2014 and July 2022 at a tertiary center. The primary outcome was any infection by 6 months.
There was no statisticall...

Alternative Titles

Full title

Long washout periods between biologics for inflammatory bowel disease clinical trials are unnecessary: A Canadian retrospective cohort study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2835278341

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2835278341

Other Identifiers

ISSN

0002-9270

E-ISSN

1572-0241

DOI

10.14309/ajg.0000000000002398

How to access this item